ALPHA TEKNOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
ALPHA TEKNOVA, INC. (TKNO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.49% for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2024-11-08
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-09-30 was 3.49%, a 23.13% decline year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 4.33%, a 5.35% increase year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-09-30 was 4.54%, a 30.09% increase year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-06-30 was 3.47%, a 19.66% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month |
|---|---|---|---|
| 2024-09-30 | 3.49% 10-Q · filed 2024-11-08 | 4.33% 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 4.33% 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 4.33% 10-Q · filed 2024-05-13 | ||
| 2023-09-30 | 4.54% 10-Q · filed 2024-11-08 | 4.15% 10-Q · filed 2024-11-08 | |
| 2023-06-30 | 3.47% 10-Q · filed 2024-08-13 | 4.11% 10-Q · filed 2024-08-13 | |
| 2023-03-31 | 4.11% 10-Q · filed 2024-05-13 | ||
| 2022-09-30 | 3.49% 10-Q · filed 2022-11-14 | 2.19% 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 2.90% 10-Q · filed 2022-08-11 | 2.09% 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 2.01% 10-Q · filed 2022-05-12 | ||
| 2021-09-30 | 0.99% 10-Q · filed 2022-11-14 | 0.93% 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 1.05% 10-Q · filed 2022-08-11 | 0.91% 10-Q · filed 2022-08-11 | |
| 2021-03-31 | 0.48% 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |